Resveratrol ameliorates mitochondrial biogenesis and reproductive outcomes in women with polycystic ovary syndrome undergoing assisted reproduction: a randomized, triple-blind, placebo-controlled clinical trial.

Negar Ajabi Ardehjani; Marzieh Agha-Hosseini; Maryam Shabani Nashtaei; Mahshad Khodarahmian; Maryam Shabani; Masoome Jabarpour; Farzane Fereidouni; Tayebeh Rastegar; Fardin Amidi

doi:10.1186/s13048-024-01470-9

Resveratrol ameliorates mitochondrial biogenesis and reproductive outcomes in women with polycystic ovary syndrome undergoing assisted reproduction: a randomized, triple-blind, placebo-controlled clinical trial.

Negar Ajabi Ardehjani, Marzieh Agha-Hosseini, Maryam Shabani Nashtaei, Mahshad Khodarahmian, Maryam Shabani, Masoome Jabarpour, Farzane Fereidouni, Tayebeh Rastegar, Fardin Amidi

Journal of ovarian research · 2024 · doi:10.1186/s13048-024-01470-9 · PMID:38987824 · PMC11234766

OA: gold CC-BY-4.0

📄 Open PDF View on PubMed View at publisher

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (79)

A randomized exploratory trial to assess the effects of resveratrol on VEGF and TNF-α 2 expression in endometriosis women via crossref
Astaxanthin treatment ameliorates ER stress in polycystic ovary syndrome patients: a randomized clinical trial. via crossref
Classification of endometriosis via crossref
Effects of resveratrol on VEGF & HIF1 genes expression in granulosa cells in the angiogenesis pathway and laboratory parameters of polycystic ovary syndrome: a triple-blind randomized clinical trial. via crossref
Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. via crossref
Hypoxia: Role of SIRT1 and the protective effect of resveratrol in ovarian function. via crossref
The impact of resveratrol on the outcome of the in vitro fertilization: an exploratory randomized placebo-controlled trial. via crossref
The Maribor consensus: report of an expert meeting on the development of performance indicators for clinical practice in ART. via crossref
Therapeutic Approaches of Resveratrol on Endometriosis via Anti-Inflammatory and Anti-Angiogenic Pathways via crossref
Utility of antioxidants during assisted reproductive techniques: an evidence based review. via crossref
doi:10.1093/advances/nmab141 via crossref
doi:10.3390/nu10101423 via crossref
doi:10.1186/1742-4933-10-28 via crossref
doi:10.1016/j.cell.2006.11.013 via crossref
doi:10.1210/jc.2016-1858 via crossref
doi:10.1111/aji.13186 via crossref
doi:10.1016/j.fertnstert.2020.08.016 via crossref
doi:10.1210/clinem/dgaa839 via crossref
doi:10.1093/ejendo/lvad096 via crossref
doi:10.1093/humrep/deh098 via crossref
doi:10.1007/s00592-017-1098-3 via crossref
doi:10.1186/1479-5868-8-115 via crossref
doi:10.1016/j.mito.2021.04.003 via crossref
doi:10.1093/nar/gkq735 via crossref
doi:10.1093/nar/gkac720 via crossref
doi:10.1016/j.mefs.2014.04.005 via crossref
doi:10.1007/s10815-011-9613-x via crossref
doi:10.1093/humrep/der037 via crossref
doi:10.1016/j.fertnstert.2015.11.026 via crossref
doi:10.1093/humrep/del151 via crossref
doi:10.1097/ogx.0b013e31815e85fc via crossref
doi:10.1186/s12958-019-0509-4 via crossref
doi:10.1002/ptr.5501 via crossref
doi:10.1007/s12011-016-0861-6 via crossref
doi:10.1016/j.biopha.2022.113642 via crossref
doi:10.1262/jrd.2015-001 via crossref
doi:10.1016/j.fertnstert.2013.10.041 via crossref
doi:10.2337/db07-0275 via crossref
doi:10.1371/journal.pgen.1007544 via crossref
doi:10.1016/s1673-8527(08)60099-5 via crossref
doi:10.1002/mc.22373 via crossref
doi:10.1371/journal.pone.0042423 via crossref
doi:10.1016/j.metabol.2011.04.010 via crossref
doi:10.1530/eje-11-0419 via crossref
doi:10.1210/jc.2011-0278 via crossref
doi:10.1093/oxfordjournals.humrep.a135954 via crossref
doi:10.1095/biolreprod.104.032391 via crossref
doi:10.1016/j.theriogenology.2015.01.029 via crossref
doi:10.1016/j.theriogenology.2022.11.048 via crossref
doi:10.1371/journal.pone.0094488 via crossref
doi:10.1093/humrep/des437 via crossref
doi:10.1139/o10-012 via crossref
doi:10.1177/1933719115570900 via crossref
doi:10.1016/j.fertnstert.2018.01.020 via crossref
doi:10.1093/humupd/dmv029 via crossref
doi:10.3109/09513590.2011.589925 via crossref
doi:10.3109/09513590.2011.564687 via crossref
doi:10.1080/14767058.2021.1958313 via crossref
doi:10.1016/j.rbmo.2019.03.205 via crossref
doi:10.1016/s0015-0282(01)02859-x via crossref
doi:10.1158/1940-6207.capr-09-0155 via crossref
doi:10.3390/nu10121892 via crossref
doi:10.1016/j.biopha.2021.112164 via crossref
doi:10.1186/s12967-014-0223-0 via crossref
doi:10.1111/j.1749-6632.2010.05853.x via crossref
doi:10.1017/s0007114521003330 via crossref
doi:10.15171/apb.2018.036 via crossref
doi:10.1016/j.clnu.2021.02.004 via crossref
doi:10.1530/jme-21-0177 via crossref
doi:10.1016/j.diabet.2018.05.010 via crossref
doi:10.3390/ijms22041667 via crossref
doi:10.1038/s41598-023-42468-5 via crossref
doi:10.1093/cvr/cvn098 via crossref
doi:10.1038/s41598-020-75107-4 via crossref
doi:10.1002/jcp.29540 via crossref
doi:10.3390/ijms241713123 via crossref
doi:10.1186/s13104-019-4453-3 via crossref
doi:10.3389/fmolb.2021.620683 via crossref
doi:10.3892/mmr.2014.2724 via crossref

Source provenance

crossref: last seen: 2026-05-20T01:00:15.923482+00:00
europepmc: last seen: 2026-06-04T01:30:01.192114+00:00
unpaywall: last seen: 2026-05-21T05:10:58.409756+00:00

License: CC-BY-4.0

[1] A randomized exploratory trial to assess the effects of resveratrol on VEGF and TNF-α 2 expression in endometriosis women via crossref

[2] Astaxanthin treatment ameliorates ER stress in polycystic ovary syndrome patients: a randomized clinical trial. via crossref

[3] Classification of endometriosis via crossref

[4] Effects of resveratrol on VEGF & HIF1 genes expression in granulosa cells in the angiogenesis pathway and laboratory parameters of polycystic ovary syndrome: a triple-blind randomized clinical trial. via crossref

[5] Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. via crossref

[6] Hypoxia: Role of SIRT1 and the protective effect of resveratrol in ovarian function. via crossref

[7] The impact of resveratrol on the outcome of the in vitro fertilization: an exploratory randomized placebo-controlled trial. via crossref

[8] The Maribor consensus: report of an expert meeting on the development of performance indicators for clinical practice in ART. via crossref

[9] Therapeutic Approaches of Resveratrol on Endometriosis via Anti-Inflammatory and Anti-Angiogenic Pathways via crossref

[10] Utility of antioxidants during assisted reproductive techniques: an evidence based review. via crossref

[11] doi:10.1093/advances/nmab141 via crossref

[12] doi:10.3390/nu10101423 via crossref

[13] doi:10.1186/1742-4933-10-28 via crossref

[14] doi:10.1016/j.cell.2006.11.013 via crossref

[15] doi:10.1210/jc.2016-1858 via crossref

[16] doi:10.1111/aji.13186 via crossref

[17] doi:10.1016/j.fertnstert.2020.08.016 via crossref

[18] doi:10.1210/clinem/dgaa839 via crossref

[19] doi:10.1093/ejendo/lvad096 via crossref

[20] doi:10.1093/humrep/deh098 via crossref

[21] doi:10.1007/s00592-017-1098-3 via crossref

[22] doi:10.1186/1479-5868-8-115 via crossref

[23] doi:10.1016/j.mito.2021.04.003 via crossref

[24] doi:10.1093/nar/gkq735 via crossref

[25] doi:10.1093/nar/gkac720 via crossref

[26] doi:10.1016/j.mefs.2014.04.005 via crossref

[27] doi:10.1007/s10815-011-9613-x via crossref

[28] doi:10.1093/humrep/der037 via crossref

[29] doi:10.1016/j.fertnstert.2015.11.026 via crossref

[30] doi:10.1093/humrep/del151 via crossref

[31] doi:10.1097/ogx.0b013e31815e85fc via crossref

[32] doi:10.1186/s12958-019-0509-4 via crossref

[33] doi:10.1002/ptr.5501 via crossref

[34] doi:10.1007/s12011-016-0861-6 via crossref

[35] doi:10.1016/j.biopha.2022.113642 via crossref

[36] doi:10.1262/jrd.2015-001 via crossref

[37] doi:10.1016/j.fertnstert.2013.10.041 via crossref

[38] doi:10.2337/db07-0275 via crossref

[39] doi:10.1371/journal.pgen.1007544 via crossref

[40] doi:10.1016/s1673-8527(08)60099-5 via crossref

[41] doi:10.1002/mc.22373 via crossref

[42] doi:10.1371/journal.pone.0042423 via crossref

[43] doi:10.1016/j.metabol.2011.04.010 via crossref

[44] doi:10.1530/eje-11-0419 via crossref

[45] doi:10.1210/jc.2011-0278 via crossref

[46] doi:10.1093/oxfordjournals.humrep.a135954 via crossref

[47] doi:10.1095/biolreprod.104.032391 via crossref

[48] doi:10.1016/j.theriogenology.2015.01.029 via crossref

[49] doi:10.1016/j.theriogenology.2022.11.048 via crossref

[50] doi:10.1371/journal.pone.0094488 via crossref

[51] doi:10.1093/humrep/des437 via crossref

[52] doi:10.1139/o10-012 via crossref

[53] doi:10.1177/1933719115570900 via crossref

[54] doi:10.1016/j.fertnstert.2018.01.020 via crossref

[55] doi:10.1093/humupd/dmv029 via crossref

[56] doi:10.3109/09513590.2011.589925 via crossref

[57] doi:10.3109/09513590.2011.564687 via crossref

[58] doi:10.1080/14767058.2021.1958313 via crossref

[59] doi:10.1016/j.rbmo.2019.03.205 via crossref

[60] doi:10.1016/s0015-0282(01)02859-x via crossref

[61] doi:10.1158/1940-6207.capr-09-0155 via crossref

[62] doi:10.3390/nu10121892 via crossref

[63] doi:10.1016/j.biopha.2021.112164 via crossref

[64] doi:10.1186/s12967-014-0223-0 via crossref

[65] doi:10.1111/j.1749-6632.2010.05853.x via crossref

[66] doi:10.1017/s0007114521003330 via crossref

[67] doi:10.15171/apb.2018.036 via crossref

[68] doi:10.1016/j.clnu.2021.02.004 via crossref

[69] doi:10.1530/jme-21-0177 via crossref

[70] doi:10.1016/j.diabet.2018.05.010 via crossref

[71] doi:10.3390/ijms22041667 via crossref

[72] doi:10.1038/s41598-023-42468-5 via crossref

[73] doi:10.1093/cvr/cvn098 via crossref

[74] doi:10.1038/s41598-020-75107-4 via crossref

[75] doi:10.1002/jcp.29540 via crossref

[76] doi:10.3390/ijms241713123 via crossref

[77] doi:10.1186/s13104-019-4453-3 via crossref

[78] doi:10.3389/fmolb.2021.620683 via crossref

[79] doi:10.3892/mmr.2014.2724 via crossref